Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Levetiracetam × Lymphoid × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Rituximab 167 Cyclophosphamide 158 fludarabine 76 Lenalidomide 73 Vincristine 70 fludarabine phosphate 63 Etoposide 59 Doxorubicin 56 Prednisone 54 venetoclax 49 Cytarabine 48 Dexamethasone 43 Filgrastim 39 Peripheral Blood Stem Cell Transplantation 38 Methotrexate 38 Bendamustine Hydrochloride 38 ibrutinib 37 obinutuzumab 36 Gemcitabine 31 Melphalan 27 Bortezomib 27 pembrolizumab 26 Alemtuzumab 25 Radiotherapy 23 Nivolumab 21 Carboplatin 21 Tacrolimus 20 Granulocyte Colony-Stimulating Factor 20 Busulfan 20 Whole-Body Irradiation 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02348216 2024-06-04

ZUMA-1

Gilead Sciences

Phase 1/2 Completed

307 enrolled 41 charts

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡